Enhancement, Efficiency, Equity, and Engagement: Four Trends Shaping Clinical Trials in 2024
ACRP blog
JANUARY 3, 2024
Diversity and Equity at the Forefront The U.S. Food and Drug Administration will require clinical trial stakeholders, including researchers and sponsors seeking approval for late-stage clinical trials, to submit diversity plans for participants in their trials.
Let's personalize your content